Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213 - Coleman, R L; Brady, M F; Herzog, T J (J Clin Oncol, 2016)
(suppl; abstr 5523)